Topographical Distribution of Morphological Changes in a Partial Model of Parkinson's Disease--Effects of Nanoencapsulated Neurotrophic Factors Administration. [electronic resource]
- Molecular neurobiology Oct 2015
- 846-58 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1559-1182
10.1007/s12035-015-9234-y doi
Animals Corpus Striatum--drug effects DNA Replication Doublecortin Domain Proteins Doublecortin Protein Drug Synergism Drug Therapy, Combination Glial Cell Line-Derived Neurotrophic Factor--administration & dosage Glial Fibrillary Acidic Protein--analysis Injections, Intralesional Male Microtubule-Associated Proteins--analysis Nanocapsules Nerve Tissue Proteins--analysis Neuroglia--chemistry Neurons--chemistry Neuropeptides--analysis Oxidopamine--toxicity Parkinsonian Disorders--drug therapy Rats Rats, Sprague-Dawley Tissue Distribution Tyrosine 3-Monooxygenase--analysis Vascular Endothelial Growth Factor A--administration & dosage